Status:
Awaiting development
Technology type:
Medicine
Decision:
Selected
Prioritisation programme:
Medicines evaluation
Rationale:

Review of TA1069.

Process:
STA Standard
ID number:
12493

Provisional Schedule

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators:
21 July 2026 - 04 August 2026

Project Team

Project lead
Jeremy Powell

Email enquiries

If you have any queries please email TACommB@nice.org.uk

Timeline

Key events during the development of the guidance:

Date Update
08 June 2026 Awaiting development. Status change linked to topic prioritisation decision being set to Selected

For further information on our processes and methods, please see our CHTE processes and methods manual